These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17241096)

  • 41. CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery.
    Stewart AJ; O'Farrell DA; Bellon JR; Hansen JL; Duggan C; Czerminska MA; Cormack RA; Devlin PM
    Brachytherapy; 2005; 4(3):224-9. PubMed ID: 16182223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of chronic toxicities between brachytherapy-based accelerated partial breast irradiation and whole breast irradiation using intensity modulated radiotherapy.
    Wobb JL; Shah C; Jawad MS; Wallace M; Dilworth JT; Grills IS; Ye H; Chen PY
    Breast; 2015 Dec; 24(6):739-44. PubMed ID: 26459227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A dosimetric analysis comparing electron beam with the MammoSite brachytherapy applicator for intact breast boost.
    Shah AP; Strauss JB; Kirk MC; Chen SS; Dickler A
    Phys Med; 2010 Apr; 26(2):80-7. PubMed ID: 19836283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
    Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
    Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT.
    Deutsch I; Zelefsky MJ; Zhang Z; Mo Q; Zaider M; Cohen G; Cahlon O; Yamada Y
    Brachytherapy; 2010; 9(4):313-8. PubMed ID: 20685176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison.
    Borghero YO; Salehpour M; McNeese MD; Stovall M; Smith SA; Johnson J; Perkins GH; Strom EA; Oh JL; Kirsner SM; Woodward WA; Yu TK; Buchholz TA
    Radiother Oncol; 2007 Mar; 82(3):324-8. PubMed ID: 17157944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IMRT for the breast: a comparison of tangential planning techniques.
    Smith W; Menon G; Wolfe N; Ploquin N; Trotter T; Pudney D
    Phys Med Biol; 2010 Feb; 55(4):1231-41. PubMed ID: 20124651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
    Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
    Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
    Duan J; Kim RY; Elassal S; Lin HY; Shen S
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):765-71. PubMed ID: 18164832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary Results in 173 Breast Cancer Patients Treated with Post-Lumpectomy MammoSite Single-Lumen Brachytherapy or Multi-Catheter Brachytherapy.
    Wilder RB; Curcio LD; Khanijou RK; Eisner ME; Kakkis JL; Chittenden L; Agustin J; Lizarde J; Mesa AV; Macedo JC; Ravera J; Tokita KM
    Breast J; 2010; 16(6):581-6. PubMed ID: 21070434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
    Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
    Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of three APBI techniques under NSABP B-39 guidelines.
    Scanderbeg D; Yashar C; White G; Rice R; Pawlicki T
    J Appl Clin Med Phys; 2009 Dec; 11(1):3021. PubMed ID: 20160680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative dosimetric and radiobiological assessment among a nonstandard RapidArc, standard RapidArc, classical intensity-modulated radiotherapy, and 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecologic cancer.
    Pedicini P; Caivano R; Fiorentino A; Strigari L; Califano G; Barbieri V; Sanpaolo P; Castaldo G; Benassi M; Fusco V
    Med Dosim; 2012; 37(4):347-52. PubMed ID: 22382087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.